NEOS Investment Management’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-14,260	Closed	-$128K	–	630
2025 Q4	$128K	Sell	14,260 -460	-3%	-$6.33K	﹤0.01%	650
2025 Q3	$254K	Sell	14,720 -9,333	-39%	-$115K	﹤0.01%	617
2025 Q2	$226K	Sell	24,053 -2,484	-9%	-$20.4K	﹤0.01%	607
2025 Q1	$189K	Sell	26,537 -101,289	-79%	-$1.02M	﹤0.01%	589
2024 Q4	$1.49M	Sell	127,826 -28,388	-18%	-$443K	0.04%	340
2024 Q3	$3.21M	Buy	156,214 +6,584	+4%	+$152K	0.1%	189
2024 Q2	$3.35M	Buy	149,630 +74,960	+100%	+$1.78M	0.14%	136
2024 Q1	$2.05M	Buy	74,670 +43,957	+143%	+$1.22M	0.13%	152
2023 Q4	$936K	Buy	+30,713	New	+$883K	0.09%	193